1. Home
  2. DMRA vs PRGO Comparison

DMRA vs PRGO Comparison

Compare DMRA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$24.85

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$11.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRA
PRGO
Founded
2011
1887
Country
United States
Ireland
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
DMRA
PRGO
Price
$24.85
$11.77
Analyst Decision
Buy
Buy
Analyst Count
1
3
Target Price
$46.00
$19.33
AVG Volume (30 Days)
217.1K
2.9M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
9.92%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.50
$9.23
52 Week High
$28.76
$28.44

Technical Indicators

Market Signals
Indicator
DMRA
PRGO
Relative Strength Index (RSI) 46.18 58.88
Support Level $23.65 $9.24
Resistance Level $28.00 $15.08
Average True Range (ATR) 2.13 0.45
MACD -0.14 0.15
Stochastic Oscillator 28.16 80.63

Price Performance

Historical Comparison
DMRA
PRGO

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: